Medicare Part B premiums should be means-tested more aggressively

Medicare Part B/D, Medicare Advantage, IRA drug negotiations, 340B, most-favored-nation pricing, and federal drug pricing policy.

Medicaid cuts, funding freezes, state waivers, directed payments, CHIP, and state-level healthcare access policies.

Medical debt, out-of-pocket costs, voter concerns, racial disparities, rural access, and international healthcare access.

Nurse shortages, telehealth expansion, NHS workforce, hospital consolidation, and psychiatric care access.

ACA enrollment, premiums, marketplace cancellations, Essential Plan, uninsured rate, and insurance regulation.

Medicare Part B premium increases, Part D premium changes, IRMAA surcharges, and out-of-pocket cost caps for 2026.